Kala Bio, Inc., a pharmaceutical company based in Arlington, MA, with a market capitalization of $66 million, disclosed the immediate resignation of its Chief Executive Officer, Mark Iwicki, on ...
ARLINGTON, Mass. - KALA BIO, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on developing treatments for rare and severe eye diseases, announced a change in its executive leadership on Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback